Cargando…

Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays

BACKGROUND: Schistosomiasis is responsible for a tremendous public health burden, yet only a single drug, praziquantel, is available. New antischistosomal treatments should therefore be developed. The accuracy, speed and objectivity of in vitro drug screening depend on the assay read-out. Microscopy...

Descripción completa

Detalles Bibliográficos
Autores principales: Panic, Gordana, Flores, Dayana, Ingram-Sieber, Katrin, Keiser, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672532/
https://www.ncbi.nlm.nih.gov/pubmed/26644133
http://dx.doi.org/10.1186/s13071-015-1233-3
_version_ 1782404587468095488
author Panic, Gordana
Flores, Dayana
Ingram-Sieber, Katrin
Keiser, Jennifer
author_facet Panic, Gordana
Flores, Dayana
Ingram-Sieber, Katrin
Keiser, Jennifer
author_sort Panic, Gordana
collection PubMed
description BACKGROUND: Schistosomiasis is responsible for a tremendous public health burden, yet only a single drug, praziquantel, is available. New antischistosomal treatments should therefore be developed. The accuracy, speed and objectivity of in vitro drug screening depend on the assay read-out. Microscopy is still the current gold standard and is in need of updating to an automated format. The aim of the present study was to investigate a panel of fluorescence/luminescence dyes for their applicability as viability markers in drug sensitivity assays for Schistosoma mansoni schistosomula. METHODS: A search for available viability and cytotoxicity marker assays and dyes was carried out and a short-list of the most interesting candidates was created. The selected kits and dyes were tested on S. mansoni Newly Transformed Schistosomula (NTS), first to assess whether they correlate with parasite viability, with comparatively low background noise, and to optimise assay conditions. Markers fulfilling these criteria were then tested in a dose–response drug assay using standard and experimental drugs and those for which an IC(50) value could be accurately and reproducibly calculated were also tested on a subset of a compound library to determine their hit-identification accuracy. RESULTS: Of the 11 markers selected for testing, resazurin, Vybrant® and CellTiter-Glo® correlated best with NTS viability, produced signals ≥ 3-fold stronger than background noise and revealed a significant signal-to-NTS concentration relationship. Of these, CellTiter-Glo® could be used to accurately determine IC(50) values for antischistosomals. Use of CellTiter-Glo® in a compound subset screen identified 100 % of hits that were identified using standard microscopic evaluation. CONCLUSION: This study presents a comprehensive overview of the utility of colorimetric markers in drug screening. Our study demonstrates that it is difficult to develop a simple, cheap “just add” colorimetric marker-based drug assay for the larval stage of S. mansoni. CellTiter-Glo® can likely be used for endpoint go/no go screens and potentially for drug dose–response studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-015-1233-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4672532
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46725322015-12-09 Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays Panic, Gordana Flores, Dayana Ingram-Sieber, Katrin Keiser, Jennifer Parasit Vectors Research BACKGROUND: Schistosomiasis is responsible for a tremendous public health burden, yet only a single drug, praziquantel, is available. New antischistosomal treatments should therefore be developed. The accuracy, speed and objectivity of in vitro drug screening depend on the assay read-out. Microscopy is still the current gold standard and is in need of updating to an automated format. The aim of the present study was to investigate a panel of fluorescence/luminescence dyes for their applicability as viability markers in drug sensitivity assays for Schistosoma mansoni schistosomula. METHODS: A search for available viability and cytotoxicity marker assays and dyes was carried out and a short-list of the most interesting candidates was created. The selected kits and dyes were tested on S. mansoni Newly Transformed Schistosomula (NTS), first to assess whether they correlate with parasite viability, with comparatively low background noise, and to optimise assay conditions. Markers fulfilling these criteria were then tested in a dose–response drug assay using standard and experimental drugs and those for which an IC(50) value could be accurately and reproducibly calculated were also tested on a subset of a compound library to determine their hit-identification accuracy. RESULTS: Of the 11 markers selected for testing, resazurin, Vybrant® and CellTiter-Glo® correlated best with NTS viability, produced signals ≥ 3-fold stronger than background noise and revealed a significant signal-to-NTS concentration relationship. Of these, CellTiter-Glo® could be used to accurately determine IC(50) values for antischistosomals. Use of CellTiter-Glo® in a compound subset screen identified 100 % of hits that were identified using standard microscopic evaluation. CONCLUSION: This study presents a comprehensive overview of the utility of colorimetric markers in drug screening. Our study demonstrates that it is difficult to develop a simple, cheap “just add” colorimetric marker-based drug assay for the larval stage of S. mansoni. CellTiter-Glo® can likely be used for endpoint go/no go screens and potentially for drug dose–response studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13071-015-1233-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-08 /pmc/articles/PMC4672532/ /pubmed/26644133 http://dx.doi.org/10.1186/s13071-015-1233-3 Text en © Panic et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Panic, Gordana
Flores, Dayana
Ingram-Sieber, Katrin
Keiser, Jennifer
Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
title Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
title_full Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
title_fullStr Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
title_full_unstemmed Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
title_short Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
title_sort fluorescence/luminescence-based markers for the assessment of schistosoma mansoni schistosomula drug assays
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672532/
https://www.ncbi.nlm.nih.gov/pubmed/26644133
http://dx.doi.org/10.1186/s13071-015-1233-3
work_keys_str_mv AT panicgordana fluorescenceluminescencebasedmarkersfortheassessmentofschistosomamansonischistosomuladrugassays
AT floresdayana fluorescenceluminescencebasedmarkersfortheassessmentofschistosomamansonischistosomuladrugassays
AT ingramsieberkatrin fluorescenceluminescencebasedmarkersfortheassessmentofschistosomamansonischistosomuladrugassays
AT keiserjennifer fluorescenceluminescencebasedmarkersfortheassessmentofschistosomamansonischistosomuladrugassays